Muscle Channelopathies Flashcards
Malignant Hyperthermia
Autosomal dominant
Abnormal response to general anaesthetic - halothane
80% death rate and 10% death rate in those treated
Symptoms of malignant hyperthermia
Tachypnea Tachycardia Low plasma O2 High plasma CO2 Rigidity Sweating Shifts in blood pressure
What happens if malignant hyperthermia is not treated and why does this lead to death?
Get respiratory and lactic acidosis Go into anaerobic respiration which leads to metabolic acidosis Muscular rigidity which leads to the breakdown of muscles, this releases K+ Severe hyperkalaemia Cardiac and neuronal excitability Leads to death because: Uncontrolled muscle contraction Excessive ATP hydrolysis Hypermetabolic state of muscles
What causes malignant hyperthermia?
Gain of function mutation in RyR1 on skeletal muscle SR
Position 614
Describe what happens when a patient with a 614 gain of function mutation in the RyR1 receptor is exposed to halothane
- RyR1 has increased sensitivity to halothane and so will cause excess release of Ca2+ from SR
- Enhanced contraction leads to rigidity
- Also leads to increased ATP hydrolysis - resulting in heat and hyperthermia
- Lactic acid production - metabolic acidosis
- Increased use of oxygen to make ATP leading to low plasma O2 concentrations
- Increased production of CO2
- Increase ventilation rate to remove CO2
- Increased HR to supply O2
What are the treatments for malignant hyperthermia
Bantrolene - inhibits RyR1 IV hydration Diuretics to stop kidney damage NaHCO3 to counteract acidosis Mechanical ventilation to remove CO2
Myotonia
Hyperexcitability in skeletal muscle
Muscle stiffness
Runs of action potentials with delayed relaxation
Myotonic seizures
What are the two forms of myotonia?
Myotonia congenita and paramyotonia
Myotonia congenita
Thomson’s autosomal dominant
Becker’s autosomal recessive
Both these mutations are on the same gene but at different locations
Loss of function in CLC1
Describe the normal function of CLC1
4 CLC1 come together to form one functional channel - a voltage dependent chloride channel
CLC1 channels are kept open at rest to keep negative membrane potential
Describe the loss of function CLC1 mutation effects
- Loss of contribution of CLC1 to the Vm
- Channels function but there is a change in the voltage dependence
- This leads to a less negative membrane potential
- Resting potential is slightly depolarised and so there is increased excitability
- Smaller depolarisation needed to reach threshold
- Number of action potentials per unit time is higher
- Contraction
Treatments for myotonia congenita
Moxilitene - inhibits voltage gated Na+ channels so reduce the depolarisation phase, however a submaximal dose must be given
Paramyotonia
Issues with the inactivation gate
Channels do not close when they should
Depolarisation phase is prolonged and therefore there is prolonged contraction
SCN4A Nav1.4 gain of function mutation